Adverse event totals18

The totals the trial posted for each group.

1 to 18 of 18

Total	Group	Affected	At risk
Total, all-cause mortality	High Dose	14	172
Total, all-cause mortality	Intermediate Dose	8	172
Total, all-cause mortality	Low Dose	13	172
Total, all-cause mortality	Switch Dose	1	37
Total, all-cause mortality	Allopurinol	10	171
Total, all-cause mortality	Placebo	11	173
Total, other adverse events	High Dose	32	172
Total, other adverse events	Intermediate Dose	32	172
Total, other adverse events	Low Dose	28	172
Total, other adverse events	Switch Dose	1	37
Total, other adverse events	Allopurinol	39	171
Total, other adverse events	Placebo	49	173
Total, serious adverse events	High Dose	36	172
Total, serious adverse events	Intermediate Dose	39	172
Total, serious adverse events	Low Dose	40	172
Total, serious adverse events	Switch Dose	4	37
Total, serious adverse events	Allopurinol	42	171
Total, serious adverse events	Placebo	35	173

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03990363/event-totals